These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 227432)

  • 21. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
    Breier C
    Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cholesterol and triglyceride content of lipoproteins in hyperlipoproteinemia type II/a, II/b and IV].
    Romics L; Karádi I; Simonyi E
    Orv Hetil; 1980 Oct; 121(43):2629-31. PubMed ID: 7208011
    [No Abstract]   [Full Text] [Related]  

  • 23. Lipoprotein lipase. Mechanism of formation of triglyceride-rich remnant particles from very low density lipoproteins and chylomicrons.
    Higgins JM; Fielding CJ
    Biochemistry; 1975 Jun; 14(11):2288-93. PubMed ID: 166652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hyperlipoproteinemia type I].
    Bustos P; Fernández E; Radrigán E
    Rev Chil Pediatr; 1987; 58(6):481-4. PubMed ID: 3506219
    [No Abstract]   [Full Text] [Related]  

  • 25. Ascites chylomicron: a poor substrate for hepatic triglyceride lipase.
    Yamada N; Murase T; Akanuma Y; Itakura H; Kosaka K
    Clin Chim Acta; 1981 Feb; 110(1):45-9. PubMed ID: 7214713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men.
    Mitropoulos KA; Miller GJ; Reeves BE; Wilkes HC; Cruickshank JK
    Atherosclerosis; 1989 Apr; 76(2-3):203-8. PubMed ID: 2730717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
    Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal plasma triglycerides as a source of fetal fatty acids.
    Hummel L; Schwartze A; Schirrmeister W; Wagner H
    Acta Biol Med Ger; 1976; 35(12):1635-41. PubMed ID: 195430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
    Vega GL; Cater NB; Hadizadeh DR; Meguro S; Grundy SM
    Clin Pharmacol Ther; 2003 Sep; 74(3):236-44. PubMed ID: 12966367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of triglyceride rich lipoproteins with very light density by ultracentrifugation and agarose gel electrophoresis using triglyceride- and cholesterol-staining.
    Hidaka H; Tozuka M; Meyer B; Yamauchi K; Sugano M; Nakabayashi T; Katsuyama T
    Ann Clin Lab Sci; 2003; 33(2):167-78. PubMed ID: 12817621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient lipoprotein lipase deficiency with hyperchylomicronemia.
    Goldberg IJ; Paterniti JR; Franklin BH; Ginsberg HN; Ginsberg-Fellner F; Brown WV
    Am J Med Sci; 1983; 286(2):28-31. PubMed ID: 6614044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma very low density lipoprotein (VLDL) in cholesterol-fed rabbits: chylomicron remnants or liver lipoproteins?
    Thompson KH; Zilversmit DB
    J Nutr; 1983 Oct; 113(10):2002-10. PubMed ID: 6619979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model.
    Zago V; Lucero D; Macri EV; Cacciagiú L; Gamba CA; Miksztowicz V; Berg G; Wikinski R; Friedman S; Schreier L
    Ann Nutr Metab; 2010; 56(3):198-206. PubMed ID: 20203480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chylomicronaemia in multiple myeloma.
    Aviram M; Carter A; Brook JG; Tatarsky I
    Scand J Haematol; 1985 May; 34(5):436-41. PubMed ID: 4012223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic studies in an unusual case of asymptomatic familial hypobetalipoproteinemia with hypolphalipoproteinemia and fasting chylomicronemia.
    Steinberg D; Grundy SM; Mok HY; Turner JD; Weinstein DB; Brown WV; Albers JJ
    J Clin Invest; 1979 Jul; 64(1):292-301. PubMed ID: 221546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states.
    Heimberg M; Olubadewo JO; Wilcox HG
    Endocr Rev; 1985; 6(4):590-607. PubMed ID: 3908084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective deficiency of hepatic triglyceride lipase in uremic patients.
    Mordasini R; Frey F; Flury W; Klose G; Greten H
    N Engl J Med; 1977 Dec; 297(25):1362-6. PubMed ID: 200841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing's syndrome.
    Taskinen MR; Nikkilä EA; Pelkonen R; Sane T
    J Clin Endocrinol Metab; 1983 Sep; 57(3):619-26. PubMed ID: 6348067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No effect of menstrual cycle phase on basal very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
    Magkos F; Patterson BW; Mittendorfer B
    Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1243-9. PubMed ID: 16835398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.